Samsung Biologics
207940.KSSouth KoreaWorld-leading contract development and manufacturing organization (CDMO) for biopharmaceuticals; top 4 in the KOSPI.
-15.10%
Pullback·(-10% to -20%)
As of Oct 29, 2026, Samsung Biologics (207940.KS) closed at ₩1,366,000, representing a -15.10% drawdown from its all-time high of ₩1,609,000 recorded on Aug 11, 2026 (79 days ago). Returning to all-time high requires a +17.8% gain.
Current Drawdown
-15.10%
From all-time highLast Close
₩1,366,000
Oct 29, 2026
All-Time High
₩1,609,000
Aug 11, 2026
Days Below Peak
79d
Days below ATHGain to ATH
+17.8%
Needed to recoverLoading chart…
Set Drawdown Alert
Get notified when Samsung Biologics dips below your chosen threshold.
Benchmark Indexes Where Samsung Biologics is a Top Holding
Compare Samsung Biologics (207940.KS) at -15.10% against the major equity indexes it anchors.
Historical Maximum Drawdowns & Annual Drops
Deepest peak-to-trough drop recorded within each calendar year.
Over the last 10 completed years, Samsung Biologics experienced an average intra-year drawdown of -26.9% lasting an average of 126 days peak-to-trough, with its deepest drawdown reaching -51.1% in 2018.
10Y Avg Drawdown
-26.92%
Correction
Deepest Drawdown
-51.11%
2018 · Bear Market
Avg Peak-to-Trough
126 days
| Year | Max Intra-Year Drawdown | Peak High | Bottom Trough | Peak-to-Trough | Yearly Return |
|---|---|---|---|---|---|
| 2025 | -35.00%Correction | Jan 8, 2025 ₩1,538,460 | Oct 30, 2025 ₩1,000,000 | 295 days | -31.51% |
| 2024 | -15.37%Pullback | Feb 2, 2024 ₩1,321,540 | May 29, 2024 ₩1,118,460 | 117 days | +24.87% |
| 2023 | -17.78%Pullback | Jan 2, 2023 ₩1,272,310 | Sep 26, 2023 ₩1,046,150 | 267 days | -7.43% |
| 2022 | -21.84%Correction | Jan 3, 2022 ₩1,386,290 | Jan 27, 2022 ₩1,083,470 | 24 days | -8.08% |
| 2021 | -20.90%Correction | Aug 17, 2021 ₩1,521,720 | Oct 6, 2021 ₩1,203,680 | 50 days | +9.32% |
| 2020 | -30.94%Correction | Feb 10, 2020 ₩806,513 | Mar 19, 2020 ₩556,950 | 38 days | +90.76% |
| 2019 | -38.24%Bear Market | Jan 15, 2019 ₩614,776 | Aug 7, 2019 ₩379,670 | 204 days | +12.03% |
| 2018 | -51.11%Bear Market | Apr 11, 2018 ₩888,686 | Nov 12, 2018 ₩434,452 | 215 days | +4.18% |
| 2017 | -18.97%Pullback | Nov 1, 2017 ₩617,819 | Dec 7, 2017 ₩500,647 | 36 days | +145.70% |
| 2016 | -19.09%Pullback | Nov 14, 2016 ₩267,062 | Dec 2, 2016 ₩216,085 | 18 days | +4.86% |
Compare with Other Drawdowns
Frequently Asked Questions about Samsung Biologics
Click to expandHow is the current drawdown of Samsung Biologics calculated?
For Samsung Biologics, drawdown measures the percentage decline from its all-time high closing peak of ₩1,609,000 (reached on Aug 11, 2026) to its latest daily close of ₩1,366,000:
((₩1,366,000 - ₩1,609,000) / ₩1,609,000) × 100 = -15.10%
Calculations use official daily settled closes to filter out intraday wick noise. The drawdown only resets to 0.00% when a new settled close surpasses ₩1,609,000.
At what prices does Samsung Biologics enter a dip, pullback, correction, or bear market?
Measuring from Samsung Biologics's all-time high closing price of ₩1,609,000:
• -10% Dip: Triggers at ₩1,448,100
• -20% Pullback: Triggers at ₩1,287,200
• -35% Correction: Triggers at ₩1,045,850
• -35% Bear Market: Triggers at ₩1,045,850
At its latest close of ₩1,366,000 (-15.10%), Samsung Biologics is currently in Pullback territory (Moderate single-stock pullback following earnings or sector rotation (10% to 20% drop).).
How much does Samsung Biologics need to rise to reach a new all-time high?
From its current drawdown of -15.10%, Samsung Biologics must gain +17.8% from its current price of ₩1,366,000 to break even back at its all-time high of ₩1,609,000.
Because losses compound on a reduced capital base, the recovery gain required always exceeds the drawdown percentage. For example, on a hypothetical $1,000 capital base at today's price, returning to prior all-time highs equals $1,177.89 (a +$177.89 recovery increase).
What is the typical annual drawdown and duration for Samsung Biologics?
Across completed annual calendar cycles, Samsung Biologics experienced an average intra-year pullback of -26.9%, taking an average of 126 calendar days to reach bottom from its intra-year peak. The deepest annual decline occurred in 2018 with a -51.1% drop, while the mildest year was 2024 with a pullback of only -15.4%.
What is the historical maximum drawdown for Samsung Biologics?
The maximum historical drawdown recorded for Samsung Biologics across tracked cycles is -57.28%. In recent market history, its deepest calendar year decline occurred in 2018, falling -51.1% from ₩888,686 (Apr 11, 2018) down to a trough of ₩434,452 (Nov 12, 2018), spanning 215 days from peak to bottom.
Which benchmark stock indexes include Samsung Biologics as a top holding?
Samsung Biologics (207940.KS) is tracked as a top constituent holding in 1 major benchmark index:
• KOSPI (^KS11): currently at -34.86% drawdown
Educational & Informational Purpose Only: All data shown is for informational purposes only and does not constitute financial advice. Past drawdowns and recoveries are not indicative of future returns. See our Terms of Service for full disclaimers.